Search results

Second half of 2018

Scientific merit of applications for beamtime assessed.

Monash University researchers have used advanced techniques at ANSTO to investigate the production of new, elongated polymer nanocapsules with a high payload of drug nanocrystals to potentially increase drug targetability, and also decrease dosage frequency and side effects.

Government response to 2016 National Research Infrastructure Roadmap

ANSTO is a major supplier of Australia’s radioactive isotopes used in nuclear medicine, delivering around 10,000 patient doses each week.  Health-based research and development in Australia and overseas also benefit greatly from ANSTO’s unique capabilities and expertise in the detection, diagnosis and treatment of disease using nuclear and accelerator infrastructure.​

Robert Russell has been awarded his PhD

ANSTO leverages great science to deliver big outcomes. We partner with scientists and engineers and apply new technologies to provide real-world benefits. Our work improves human health, saves lives, builds our industries and protects the environment.

Explore ANSTO's range of publications and reports available for the public.

Three ANSTO scientists are contributing to two recently awarded Australian Research Council Discovery Project grants.

PHD student Dr Leonie van ‘t Hag has been awarded the prestigious 2017 ANSTO, Australian Synchrotron Stephen Wilkins Medal for her PhD thesis.